A 10-year single-institution retrospective review of treatment for acquired hemophilia A
Haemophilia
.
2023 Nov;29(6):1656-1660.
doi: 10.1111/hae.14856.
Epub 2023 Sep 11.
Authors
James F Wu
1
,
Lynn M Malec
2
3
,
Sarbagya Pandit
1
,
Haisam Abid
1
,
Pinky Jha
1
,
Lisa M Baumann Kreuziger
2
3
Affiliations
1
Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
2
Blood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee, Wisconsin, USA.
3
Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
PMID:
37694801
DOI:
10.1111/hae.14856
No abstract available
Publication types
Letter
MeSH terms
Factor VIII / therapeutic use
Hemophilia A* / therapy
Humans
Retrospective Studies
Substances
Factor VIII
Supplementary concepts
Factor 8 deficiency, acquired
Grants and funding
1R38HL167238-01/the National, Heart, Lung, and Blood Institute
the American Society of Hematology (ASH)